All‐cause mortality ‐ short‐term · Anyone diagnosed with AMI
Cells showed no clear difference in all‐cause mortality ‐ short‐term compared with no cells (moderate certainty).
1 finding from 1 review
All‐cause mortality ‐ long‐term · Anyone diagnosed with AMI
Cells showed no clear difference in all‐cause mortality ‐ long‐term compared with no cells (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · Anyone diagnosed with AMI
Cells showed no clear difference in cardiovascular mortality ‐ short‐term compared with no cells (moderate certainty).
2 findings from 1 review
Composite death, reinfarction and hospitalisation for heart failure ‐ short‐term · Anyone diagnosed with AMI
Cells showed no clear difference in composite death, reinfarction and hospitalisation for heart failure… compared with no cells (moderate certainty).
1 finding from 1 review
Composite death, reinfarction and hospitalisation for heart failure ‐ long‐term · Anyone diagnosed with AMI
Cells showed no clear difference in composite death, reinfarction and hospitalisation for heart failure… compared with no cells (moderate certainty).
1 finding from 1 review
All‐cause mortality ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes all‐cause mortality ( compared with control (very low certainty).
1 finding from 1 review
Reduction in pain Various scales including VAS, PISQ; scales ranged from 0 to 4/10/100, where 0 = no pain ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
Amputation · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes incidence of amputation ( compared with control (very low certainty).
1 finding from 1 review
Angiographic analysis · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Increase in ABI An ABI ratio of 0.9 or less indicates PAD. Values between 0.9 and 1.0 are borderline, and above 1.0 is considered normal ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
Increase in PFWD (m) ( · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
1 finding from 1 review
Complications and side effects · people with CLI who were not suitable for revascularisation and showed no improvement in response to the best standard therapy
It is very uncertain whether intramuscular injection of bone marrow mononuclear cells (BMMNC) changes side effects and complications ( compared with control (very low certainty).
1 finding from 1 review
Successful lumbar puncture procedure at the first attempt, with < 10000 red blood cells/mm3№ of participants: 1249(2 RCTs) · lumbar puncture in newborn infants
Lateral decubitus position showed no clear difference in successful lumbar puncture procedure at the first attempt, with <… compared with sitting position (moderate certainty).
1 finding from 1 review
RR 0.99 [0.88, 1.12]
Studies not reported
Moderate
Intervention not reported
Proportion of participants with success, defined as 0 to trace cells or 2‐step decrease in activity SUN‐grading ( · Participants with a diagnosis of JIA and uveitis who are aged 2 to 18 years old
The intervention showed no clear difference in proportion of participants with success, defined as 0 to trace cells… (low certainty).
1 finding from 1 review
Intervention not reported
Change from baseline in blood eosinophils (cells x 10*9/L) · children and adults with asthma
1 finding from 1 review
Number of sickle cells, peripheral erythroblasts and reticulocytes · children with SCD
1 finding from 1 review
Conjunctival goblet cell density (cells per unit) at 6 months · people with dry eye
1 finding from 1 review
Change in dense red cells in sickle cell disease · people with sickle cell disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Endothelial cell count cells/mm2, 12 months' · participants/eyes with corneal endothelial failure
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Number of participants with major bleeding within 7 days of surgery (bleeding that required ≥ 2 units of whole blood/red blood cells within 24 hours of the bleeding) · people with a low platelet count
1 finding from 1 review